NRC Group ASA (NRC.OL) stock: key figures, P/E, revenue and dividend
Industrials · Construction & Engineering · Norway · ISIN NO0003679102
NRC Group ASA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 6.89 bn NOK | 6.55 bn NOK |
| Gross profit | 2.71 bn NOK | 3.02 bn NOK |
| Operating income | -820.00 m NOK | 141.00 m NOK |
| EBIT | -820.00 m NOK | 138.00 m NOK |
| Net income | -1.00 bn NOK | 24.00 m NOK |
| Diluted EPS – continuing operations | -5.82 NOK | 0.14 NOK |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About NRC Group ASA
NRC Group ASA, together with its subsidiaries, operates as a rail infrastructure company in Norway, Sweden, and Finland. The company offers groundwork services, including excavations, transport, masses sorting, and ditching, as well as water and drainage systems; and signaling systems, digital telecom systems, electro, tracks, and station buildings and terminals, as well as catenary systems comprising wires, masts, switches, and return current systems. It also provides concrete work, recycling, demolition, and mass transport services; steel structures; and specialized trackwork services. In addition, the company engages in constructing, upgrading, and maintaining track systems, including structures, such as stations, tunnels, and bridges. The company was formerly known as Blom ASA and changed its name to NRC Group ASA in May 2015. NRC Group ASA was founded in 1966 and is headquartered in Lysaker, Norway.
More stocks
- CuriosityStream Inc. (CURI)
- Super Turtle PCL (TURTLE.BK)
- Deezer S.A. (DEEZR.PA)
- AirJoule Technologies Corp. (AIRJ)
- Fiera Capital Corporation (FSZ.TO)
- Niagen Bioscience, Inc. (NAGE)
- Fidelix Co. Ltd (032580.KQ)
- United Pharm (033270.KS)
- VINCE HOLDING CORP. (VNCE)
- Donga Geologic (028100.KS)
- OptimizeRx Corp (OPRX)
- AN2 Therapeutics, Inc. (ANTX)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.